Lifevantage Corporation (LFVN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Lifevantage Corporation (LFVN) has a cash flow conversion efficiency ratio of 0.085x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.79 Million) by net assets ($32.99 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Lifevantage Corporation - Cash Flow Conversion Efficiency Trend (1997–2025)
This chart illustrates how Lifevantage Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Lifevantage Corporation (LFVN) financial obligations for a breakdown of total debt and financial obligations.
Lifevantage Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lifevantage Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nynomic AG
F:M7U
|
-0.045x |
|
Tomei Consolidated Bhd
KLSE:7230
|
0.017x |
|
Gohigh Data Networks Technology Co Ltd
SHE:000851
|
-0.007x |
|
HY Energy Group Co Ltd
SHG:600387
|
-0.044x |
|
Value8 N.V
AS:VALUE
|
0.007x |
|
Versatile Creative Bhd
KLSE:4995
|
0.046x |
|
Chosun Welding
KO:120030
|
0.009x |
|
Jaiprakash Associates Limited
NSE:JPASSOCIAT
|
0.066x |
Annual Cash Flow Conversion Efficiency for Lifevantage Corporation (1997–2025)
The table below shows the annual cash flow conversion efficiency of Lifevantage Corporation from 1997 to 2025. For the full company profile with market capitalisation and key ratios, see Lifevantage Corporation (LFVN) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $34.64 Million | $11.88 Million | 0.343x | -24.97% |
| 2024-06-30 | $25.99 Million | $11.88 Million | 0.457x | +131.91% |
| 2023-06-30 | $34.65 Million | $6.83 Million | 0.197x | -21.97% |
| 2022-06-30 | $31.52 Million | $7.96 Million | 0.253x | -42.88% |
| 2021-06-30 | $36.81 Million | $16.27 Million | 0.442x | -19.77% |
| 2020-06-30 | $33.25 Million | $18.33 Million | 0.551x | -15.74% |
| 2019-06-30 | $27.20 Million | $17.79 Million | 0.654x | +8.28% |
| 2018-06-30 | $21.95 Million | $13.26 Million | 0.604x | +33.00% |
| 2017-06-30 | $14.53 Million | $6.60 Million | 0.454x | -7.97% |
| 2016-06-30 | $12.13 Million | $5.99 Million | 0.493x | -87.59% |
| 2015-06-30 | $3.33 Million | $13.22 Million | 3.976x | +31.06% |
| 2014-06-30 | $3.99 Million | $12.11 Million | 3.034x | +865.89% |
| 2013-06-30 | $33.95 Million | $10.66 Million | 0.314x | -54.18% |
| 2012-06-30 | $28.28 Million | $19.39 Million | 0.686x | +404.74% |
| 2011-06-30 | $-20.81 Million | $4.68 Million | -0.225x | -180.87% |
| 2010-06-30 | $-16.17 Million | $-4.50 Million | 0.278x | -63.38% |
| 2009-06-30 | $-6.85 Million | $-5.21 Million | 0.760x | +421.97% |
| 2008-06-30 | $3.17 Million | $-747.78K | -0.236x | +79.53% |
| 2007-06-30 | $2.71 Million | $-3.13 Million | -1.153x | -943.09% |
| 2006-06-30 | $8.28 Million | $-915.63K | -0.111x | +58.35% |
| 2005-06-30 | $10.98 Million | $-2.91 Million | -0.265x | -105.38% |
| 2004-06-30 | $23.49K | $-3.04K | -0.129x | +61.58% |
| 2003-06-30 | $29.72K | $-9.99K | -0.336x | +14.57% |
| 2002-06-30 | $38.16K | $-15.02K | -0.394x | +96.37% |
| 2000-06-30 | $11.74K | $-127.38K | -10.847x | -36121.45% |
| 1999-06-30 | $26.95K | $-807.00 | -0.030x | -2950.67% |
| 1998-06-30 | $105.66K | $111.00 | 0.001x | +109.86% |
| 1997-06-30 | $129.70K | $-1.38K | -0.011x | -- |
About Lifevantage Corporation
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3… Read more